Aprea Therapeutics, Inc. Conversion of Stock, Amount Issued
Aprea Therapeutics, Inc. (APRE) reported Conversion of Stock, Amount Issued of $583.70 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow
us-gaap:ConversionOfStockAmountIssued1 · last filed 2026-08-12
- Aprea Therapeutics, Inc. conversion of stock, amount issued for the quarter ending 2025-12-31 was $0.00.
- Aprea Therapeutics, Inc. conversion of stock, amount issued for the quarter ending 2025-09-30 was $0.00.
- Aprea Therapeutics, Inc. conversion of stock, amount issued for fiscal 2025 was $583.70K.
| Period end | Conversion of Stock, Amount Issued 3 month | Conversion of Stock, Amount Issued 6 month | Conversion of Stock, Amount Issued 9 month | Conversion of Stock, Amount Issued 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | $583.70K 10-K · filed 2026-03-16 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $583.70K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $583.70K 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |